Intas launches DCGI-approved Tofacitinib Topical (JAKi) in Auto-Immune Condition Atopic Dermatitis (AD) for Indian patients calcuttanews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from calcuttanews.net Daily Mail and Mail on Sunday newspapers.